Alambic Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Alambic Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-39,300	Closed	-$46K	–	408
2018 Q4	$46K	Buy	+39,300	New	+$70.7K	0.02%	293
2018 Q2	–	Sell	-18,418	Closed	-$39K	–	475
2018 Q1	$39K	Sell	18,418 -59,247	-76%	-$127K	0.01%	453
2017 Q4	$158K	Buy	+77,665	New	+$161K	0.02%	422
2016 Q3	–	Sell	-44,800	Closed	-$60K	–	569
2016 Q2	$60K	Buy	+44,800	New	+$210K	0.02%	519
2016 Q1	–	Sell	-10,597	Closed	-$83K	–	535
2015 Q4	$83K	Buy	+10,597	New	+$91.2K	0.05%	336

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Alambic Investment Management's INFI Position: Q1 2019 in Review

Alambic Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2019, closing a stake of 39,300 shares — an estimated $46K sold.

Alambic Investment Management first reported a position in INFI in Q4 2015 and held it in 5 quarters. The position peaked at $158K in Q4 2017. 63 funds tracked by Wall St. Rank hold INFI as of Q1 2019.

Alambic Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Alambic Investment Management sold 39,300 Infinity Pharmaceuticals, Inc. shares in Q1 2019, an estimated $46K.
Alambic Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2015 and held it in 5 quarters.
Alambic Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $158K in Q4 2017.
63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2019.

Based on Alambic Investment Management's 13F filing for Q1 2019, filed 9 May 2019.